Related Experiment Video
Updated: Jul 10, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Primary systemic chemotherapy for breast cancer]
Masahiro Takada1, Masakazu Toi
1Dept. of Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto University, Japan.
Neoadjuvant chemotherapy combining anthracycline and taxane improves breast cancer response rates. Targeted agents like trastuzumab further enhance effectiveness, enabling personalized treatment strategies based on early response and genetic markers.
Area of Science:
- Oncology
- Medical Chemistry
Background:
- Neoadjuvant chemotherapy is crucial for breast cancer management.
- Combination therapy with anthracycline and taxane demonstrates higher response rates.
- Molecular targeted agents, including trastuzumab, show promise in enhancing treatment efficacy.
Purpose of the Study:
- To review recent advancements in neoadjuvant chemotherapy for breast cancer.
- To highlight the role of combination therapies and targeted agents.
- To discuss the integration of genetic testing and early response assessment for tailored treatment.
Main Methods:
- Literature review of recent advances in neoadjuvant chemotherapy for breast cancer.
- Analysis of treatment response rates with different therapeutic regimens.
- Examination of the impact of molecular targeted agents and genetic markers.
Main Results:
- Combination chemotherapy (anthracycline and taxane) yields higher response rates.
- Molecular targeted agents like trastuzumab are expected to improve treatment outcomes.
- Early identification of treatment response and genetic profiling facilitate personalized therapeutic strategies.
Conclusions:
- Neoadjuvant chemotherapy, particularly combination therapy with targeted agents, is effective in breast cancer treatment.
- Tailored treatment strategies based on genetic markers and early response assessment are increasingly important.
- Further research into biological specimens can lead to novel treatment development.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...